Aleksander Wardęszkiewicz

Dr. Aleksander Wardęszkiewicz


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 May 2026 in Cancers
Verified
Journal Article
Open access
PDF file
OGOliwia Katarzyna Grząsiak-Kraj
Oliwia Katarzyna Grząsiak-Kraj
TKTomasz Kraj
Tomasz Kraj
AMAlicja Majos
Alicja Majos
AWAleksander Wardęszkiewicz
Aleksander Wardęszkiewicz
ASAneta Szmiel
Aneta Szmiel
JSJanusz Maciej Strzelczyk
Janusz Maciej Strzelczyk
Background: Pancreatic ductal adenocarcinoma (PDAC) is associated not only with tumor progression but also with profound metabolic and nutritional disturbances. Thyroid hormone homeostasis may reflect this systemic response; however, perioperative data in PDAC remain limited. We aimed to assess perioperative changes in thyroid-related parameters in patients with PDAC undergoing different types of surgical management and to explore their associations with nutritional, metabolic, and tumor-burden variables. Methods: We performed a retrospective single-center study including 101 patients with PDAC. Thyroid-related and metabolic laboratory parameters were assessed before surgery and again 4–6 weeks later. The analyzed variables included thyroid-stimulating hormone (TSH), free triiodothyronine (FT3), free thyroxine (FT4), the FT3/FT4 ratio, albumin, total protein, glucose, insulin, HbA1c, lipid parameters, and CA 19-9. Patients were analyzed according to resectional versus non-resectional treatment and according to four procedure types. The primary endpoint was perioperative change in the FT3/FT4 ratio. Results: At baseline, resectional patients had significantly higher FT3 and FT3/FT4 ratio values and lower FT4 and CA 19-9 levels than non-resectional patients. In the whole cohort, FT3 and the FT3/FT4 ratio decreased significantly after treatment, whereas TSH increased, and FT4 remained unchanged. These endocrine changes occurred in parallel with significant declines in albumin, total protein, glucose, insulin, HbA1c, and HDL cholesterol, together with an increase in triglyceride levels. Baseline FT3 and FT3/FT4 ratios correlated positively with albumin and total protein and negatively with CA 19-9. Although perioperative changes did not differ significantly between resectional and non-resectional groups except for triglycerides, significant procedure-dependent differences were observed across the four surgical categories for FT3, FT4, TSH, and the FT3/FT4 ratio; glucose; insulin; and triglycerides. The prevalence of low-T3 syndrome increased from 11.1% preoperatively to 38.7% postoperatively. Conclusions: In PDAC, perioperative changes in thyroid hormone indices are pronounced and strongly depend on the type of surgical management. FT3 and the FT3/FT4 ratio appear to reflect systemic metabolic and nutritional adaptation as well as disease burden rather than acting as tumor-specific markers.

28 October 2026 in Cancers
Verified
Journal Article
Open access
PDF file
AWAleksander Wardęszkiewicz
Aleksander Wardęszkiewicz
KKKonrad Kosztowny
Konrad Kosztowny
OGOliwia Katarzyna Grząsiak-Kraj
Oliwia Katarzyna Grząsiak-Kraj
PHPiotr Hogendorf
Piotr Hogendorf
ADAdam Durczyński
Adam Durczyński
AMAlicja Majos
Alicja Majos
Introduction: Eosinophils have become important therapeutic targets in several allergic diseases. This study aimed to apply a similar approach—using peripheral blood findings to identify features of type 2 (T2) inflammation—to oncology. We used Simple Algorithm for Blood Morphology Analysis (SAMBA) to describe blood count profiles in a cohort of patients with PDAC independently of relative ratios and propose a potential classification. Materials and Methods: We included 153 treatment-naïve patients with PDAC confirmed by postoperative histopathology. Of these, n = 68 (44.4%) underwent curative surgery, whereas n = 85 (55.6%) received palliative treatment or underwent surgical biopsy only. SAMBA was applied using laboratory reference ranges and overall survival (OS; months) as the analytical context. Results: The subgroups defined according to laboratory reference ranges did not differ significantly in disease stage, grade, or resection status. Based on correlation analyses, Kaplan–Meier curves, and a classification and regression tree (CART) analysis of OS, we propose four blood count phenotypes: exhausted, lymphopenic, T2-low, and T2-high (median OS: 1.5 months, n = 22; 4.5 months, n = 12; 8.0 months, n = 25; and 10.0 months, n = 94, respectively). Conclusions: We propose the following preliminary interpretations of these phenotypes: exhausted, potentially associated with concomitant infection or marked inflammation; lymphopenic, characterized by a low lymphocyte count and potentially reduced antitumor immune activity; eosinopenic (T2-low), characterized by a relatively balanced inflammatory profile but limited T2-associated features; and eosinophilic (T2-high), characterized by no major abnormalities in the other blood count parameters and a more favorable prognosis. SAMBA is a transparent, readily interpretable algorithm that may help standardize and accelerate preliminary research in immuno-oncology.